Skip to main content

Animations

MJFF Publications

3881 - 3890 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00561-6
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02599-5
    Citation Count: 32
  • Summary Details
    OPEN
    Title: LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2303789120
    Citation Count: 41
  • Summary Details
    OPEN
    Title: The effects of AQP4 rs162009 on resting‐state brain activity in Parkinson's disease
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/cns.14208
    Citation Count: 13
  • Summary Details
    OPEN
    Title: ATXN2 intermediate expansions in amyotrophic lateral sclerosis
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awac167
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Neurofilament light levels predict clinical progression and death in multiple system atrophy
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac253
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00439-z
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
    Journal Name: Cell Death Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41420-023-01333-0
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Impaired pre-synaptic plasticity and visual responses in auxilin-knockout mice
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.107842
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.08.005
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.